Indications and uses
To support weight management To improve glycemic control in adults with type 2 diabetes mellitus Provides long-acting sustained-release delivery via soluble microneedle patch
To support weight management To improve glycemic control in adults with type 2 diabetes mellitus Provides long-acting sustained-release delivery via soluble microneedle patch
• Apply one transdermal patch containing 20 mg Retatrutide to the wrist or the back of the hand. • Leave the patch in place for 30 to 60 minutes, then remove. • Administer once every 3 to 7 days. • Do not reuse a patch. • Use only as directed.
Retatrutide 20 mg ……………………………. Weight management / blood sugar control
Weight loss aid
Improves blood sugar control (when used with diet and exercise)
To support weight management
To improve glycemic control in adults with type 2 diabetes mellitus
Provides long-acting sustained-release delivery via soluble microneedle patch
For external use only
• Apply one transdermal patch containing 20 mg Retatrutide to the wrist or the back of the hand.
• Leave the patch in place for 30 to 60 minutes, then remove.
• Administer once every 3 to 7 days.
• Do not reuse a patch.
• Use only as directed.
• have type 1 diabetes
• need treatment for diabetic ketoacidosis
• are pregnant or breastfeeding
• are under 18 years of age
• have severe heart disease
• have skin disease or broken skin at the application site
• have a history of hypoglycemia
• are allergic to any ingredient in this product
• monitor blood glucose regularly
• possible side effects include:
– hypoglycemia
– nausea, vomiting, or diarrhea
– acute pancreatitis
– complications of diabetic retinopathy
– increased heart rate
– hypersensitivity or allergic reactions
• you develop severe abdominal pain (possible acute pancreatitis)
• symptoms of hypersensitivity occur (rash, swelling, difficulty breathing)
• persistent gastrointestinal problems occur
In case of accidental ingestion, get medical help or contact a Poison Control Center right away.
Microcrystalline matrix, soluble microneedle polymer blend, stabilizers, adhesive layer.
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84778-082-01 | Esokalli Slimming microcrystalline patch | 20 mg in 1 PATCH | PATCH | 20 | 3 | |
| 84778-082-01 | Esokalli Slimming microcrystalline patch | 1 in 1 BOX | PATCH | 1 | 3 | |
| 84778-082-02 | Esokalli Slimming microcrystalline patch | 20 mg in 1 PATCH | PATCH | 20 | 3 | |
| 84778-082-02 | Esokalli Slimming microcrystalline patch | 2 in 1 BOX | PATCH | 2 | 3 | |
| 84778-082-03 | Esokalli Slimming microcrystalline patch | 20 mg in 1 PATCH | PATCH | 20 | 3 | |
| 84778-082-03 | Esokalli Slimming microcrystalline patch | 4 in 1 BOX | PATCH | 4 | 3 | |
| 84778-082-04 | Esokalli Slimming microcrystalline patch | 8 in 1 BOX | PATCH | 8 | 3 | |
| 84778-082-04 | Esokalli Slimming microcrystalline patch | 20 mg in 1 PATCH | PATCH | 20 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84778-082 | 84778-082-01, 84778-082-02, 84778-082-03, 84778-082-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POLYVINYL ALCOHOL, UNSPECIFIED | 532B59J990 | IACT |
| RETATRUTIDE | NOP2Y096GV | ACTIB |
| SUCROSE | C151H8M554 | IACT |
| DIMETHICONE, UNSPECIFIED | 92RU3N3Y1O | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3dbbfe4e-f9c5-67c8-e063-6294a90a4644 | 3d7026b8-d2cb-f4ab-e063-6294a90aeedd | 2025-09-01 | Warnings | 3dbbfe4e-f9c5-67c8-e063-6294a90a4644 3d7026b8-d2cb-f4ab-e063-6294a90aeedd |
Adverse event summaries are temporarily unavailable. Other product information remains available.